Skip to content

Menu

RESET-RA Study
Insights
Press Releases

SCIENCE
THERAPY
COMPANY
CAREERS

Menu

Home
Science
Therapy
Company
Insights
- Press Releases
Careers
Contact
RESET-RA Study

Revolutionizing how autoimmune diseases are treated

Scientific publications

November 14, 2019

SetPoint Medical to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum 2019

October 29, 2019

SetPoint Medical Announces Oral Presentation of Results from U.S. Pilot Study in Rheumatoid Arthritis Patients at American College of Rheumatology (ACR) Annual Meeting 2019

October 24, 2019

Time – Why It’s Time to Take Electrified Medicine Seriously

October 21, 2019

Healio Rheumatology – Vagus Nerve Stimulation Wanders into Mainstream Rheumatology

September 9, 2019

MPO Magazine – Shock to the System: An Examination of Neurostim Technologies

June 17, 2019

SetPoint Medical Reports Positive Results from its U.S. Pilot Study in Rheumatoid Arthritis

June 3, 2019

SetPoint Medical to Present Results From The U.S. Pilot Study in Rheumatoid Arthritis Patients at European Congress of Rheumatology (EULAR) 2019

May 22, 2019

SetPoint Medical to Present at Guggenheim 2019 MedTech Disruptors Summit

May 20, 2019

SetPoint Medical Reports New Data Demonstrating its Bioelectronic Medicine Effectively Reduces Crohn’s Disease Activity

«‹ 2 3 4 5 ›»

CAUTION – Investigational device. Limited by United States law to investigational use.

designElement

© 2023 SetPoint Medical is a registered trademark of SetPoint Medical Corporation in the United States and other countries. By using this website you agree to our Privacy Policy.

DISCLAIMER:

The patient experience shared in this video represents a unique individual experience and does not provide any indication, guide, warranty or guarantee as to the response other people may have to these and related therapies. Responses can and do vary; the response other individuals have could be different, including no response at all. The SetPoint Medical device is an investigational device. Its use is limited by United States law to investigational use. It is not approved for commercial use.